Bioventus BVS U.S. Segment — Adjusted other segment expense

Similar metrics at other companies

XMTRUS — Segment Adjusted Operating Expense

$53.05M+17.7%

WU.S. — Other segment items

$346M+1.2%

MMSU.S. Services — Other segment items

$61.92M+6.8%

PRAAUnited States Segment — Segment Reporting, Other Segment Item, Amount

$22.16M-7.0%

IPARUnited States Based Operations — Segment Reporting Other Item Amount

$9.19M+6.5%

MURUnited States — Other segment costs (income)

$1.1M+22.2%

Questions, answered.

What is Bioventus's U.S. segment — adjusted other segment expense?

Bioventus (BVS) reported U.S. segment — adjusted other segment expense of -$252K in Q1 2026.

How has Bioventus's U.S. segment — adjusted other segment expense changed year-over-year?

Bioventus's U.S. segment — adjusted other segment expense decreased by 128.0% year-over-year, from $899K to -$252K.

What is the long-term trend for Bioventus's U.S. segment — adjusted other segment expense?

Over 3 years (2022 to 2025), Bioventus's U.S. segment — adjusted other segment expense has grown at a 13.9% compound annual growth rate (CAGR), from -$1.05M to $1.55M.

What does U.S. segment — adjusted other segment expense mean?

This metric captures miscellaneous adjusted operating expenses related to the U.S. segment that do not fall under standard cost of sales, selling, marketing, or administrative categories. It provides a comprehensive view of the total operational cost structure unique to the domestic business.